Quinlan changes company status
QUINLAN Private Capital has re-registered itself as an "unlimited" company, shielding its finances from public view.
A spokesman said the company had "no comment" to make on the move, which was confirmed in documents lodged with the Companies Registration Office. Separate documents showed Quinlan Private Capital had also increased its authorised share capital from €250,000 to €1m.
Green light for IL&P holding firm
The High Court yesterday rubber-stamped Irish Life & Permanent's (IL&P) plan to set up a holding company, which is seen as making it easier for the bancassurer to spin-off its weak banking unit. Shares in Irish Life & Permanent Holdings will start trading on January 18.
DCC report to be published in full
THE report from an inspector appointed to investigate unlawful insider dealing by DCC plc, and by its former chief executive Jim Flavin, can be supplied to all those directly affected by it before full publication next week, the Commercial Court heard yesterday. The Director of Corporate Enforcement was supporting publication in its "full and unredacted form" from next Monday, the court was told.
Patients enrolled for drug trials
Irish drug development company Amarin has enrolled the first patients to phase 3 trials for AMR101, the company's lead product candidate that aims to treat hypertriglyceridemia. High levels of fatty triglycerides can be a risk factor for cardiac disease. Meanwhile, medical devices firm Crospon has raised €2m in funding and secured approval from the US Food and Drug Administration for its flagship gastroenterology product, Endoflip.
Savings could hit spending revival
IRELAND may experience a "sluggish" revival in consumer spending as borrowers rebuild savings following a collapse in house prices, according to researchers at the Federal Reserve Bank of San Francisco. "The efforts of households in many countries to reduce their elevated debt loads via increased saving could result in sluggish recoveries of consumer spending," they said.